Caris Life Sciences
PublicCaris Life Sciences is now publicly traded
The data on this page reflects Caris Life Sciences's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Went Public
Jun 17, 2025
Last Round
Growth Equity
Apr 7, 2025
Total Funding Raised
$2.12B
Company Overview
Caris Life Sciences is a biotechnology company that specializes in cancer treatment through molecular science and artificial intelligence, providing profiling services that assess DNA, RNA, and proteins to enhance understanding of cancer biology and support personalized treatment decisions for patients and physicians.
Sector
Biotech
AI Layer
Application
Keywords
Caris Life Sciences Comparables
Compare Caris Life Sciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Tempus | 89% | |
| Guardant Health | 89% | |
| Roche Holding | 83% | |
Caris Life Sciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| IPO | Jun 17, 2025 | ||||
| Growth Equity | Apr 7, 2025 | ||||
| Debt | Jan 19, 2023 | ||||
| Growth Equity | May 11, 2021 | ||||
| Debt | Oct 27, 2020 | ||||
Debt | Oct 1, 2018 |
Caris Life Sciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CPP Investments | Growth Equity |
| Evercore ISI | ipo |
| Perceptive Advisors | Growth Equity |
| Guggenheim Securities | ipo |
| Millennium Management | Growth Equity, Debt |
| Braidwell | Debt, Growth Equity |
| Columbia Threadneedle Investments | Growth Equity |
Caris Life Sciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
